Resveratrol induces MMP-9 and cell migration via the p38 kinase and PI-3K pathways in HT1080 human fibrosarcoma cells

Gweon,Eun  Jeong; Kim,Song  Ja

doi:10.3892/or.2012.2151

Resveratrol induces MMP-9 and cell migration via the p38 kinase and PI-3K pathways in HT1080 human fibrosarcoma cells

Authors:
- Eun Jeong Gweon
- Song Ja Kim
View Affiliations

Affiliations: Department of Biological Sciences, College of Natural Sciences, Kongju National University, Gongju, Chungnam 314-701, Republic of Korea
Published online on: November 27, 2012 https://doi.org/10.3892/or.2012.2151
Pages: 826-834

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Trans-3,4',5-trihydroxystilbene (resveratrol) is a grape polyphenol present in various plants, food products, red wine and grapes. Resveratrol has anti-inflammatory, anticarcinogenic, anti-oxidant and anti-aging properties. Matrix metalloproteinases (MMPs) are key enzymes involved in the degradation of the extracellular matrix, and their expression may be regulated in cancer metastasis. In the present study, we aimed to evaluate the effect of resveratrol on MMPs and cell migration, and to understand the mechanism of action in HT1080 human fibrosarcoma cells. We found that resveratrol inhibited HT1080 cell viability at various concentrations as detected by the MTT assay and FACS analysis. However, resveratrol dramatically increased the activation and expression of MMP-9 in a dose- and time-dependent manner, as determined by gelatin zymography assay and western blot analysis. We also discovered that resveratrol enhanced the migratory ability of HT1080 cells, as determined by the wound healing assay, and decreased the phosphorylation of p38 kinase. Moreover, the Akt kinase was inhibited by resveratrol in the HT1080 cells. The inhibition of p38 and Akt kinases with SB203580 and LY294002 further increased resveratrol-induced MMP-9 as well as cell migration in the HT1080 cells. Our results suggest that resveratrol regulates MMP-9 and migratory abilities through the p38 kinase and PI-3K pathways in HT1080 human fibrosarcoma cells.

View Figures

View References

1	Brisdelli F, D’Andrea G and Bozzi A: Resveratrol: a natural polyphenol with multiple chemopreventive properties. Curr Drug Metab. 10:530–546. 2009. View Article : Google Scholar : PubMed/NCBI
2	Cao Y, Cao R and Brakenhielm E: Antiangiogenic mechanisms of diet-derived polyphenols. J Nutr Biochem. 13:380–390. 2002. View Article : Google Scholar : PubMed/NCBI
3	Brakenhielm E, Cao R and Cao Y: Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J. 15:1798–1800. 2001.PubMed/NCBI
4	Aquilano K, Baldelli S, Rotilio G and Ciriolo MR: Trans-Resveratrol inhibits H₂O₂-induced adenocarcinoma gastric cell proliferation via inactivation of MEK1/2-ERK1/2-c-jun signalling axis. Biochem Pharmacol. 77:337–347. 2009.PubMed/NCBI
5	Kozuki Y, Miura Y and Yagasaki K: Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action. Cancer Lett. 167:151–156. 2001. View Article : Google Scholar : PubMed/NCBI
6	Woo JH, Lim JH, Kim YH, et al: Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene. 23:1845–1853. 2004. View Article : Google Scholar
7	Sun C, Hu Y, Liu X, et al: Resveratrol downregulates the constitutional activation of nuclear factor-kappaB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis. Cancer Genet Cytogenet. 165:9–19. 2006. View Article : Google Scholar : PubMed/NCBI
8	Klinge CM, Blankenship KA, Risinger KE, et al: Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem. 280:7460–7468. 2005. View Article : Google Scholar : PubMed/NCBI
9	Aziz MH, Kumar R and Ahmad N: Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (Review). Int J Oncol. 23:17–28. 2003.PubMed/NCBI
10	Tang FY, Chiang EP and Sun YC: Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells. J Nutr Biochem. 19:287–294. 2008. View Article : Google Scholar : PubMed/NCBI
11	Yilmaz M, Christofori G and Lehembre F: Distinct mechanisms of tumor invasion and metastasis. Trends Mol Med. 13:535–541. 2007. View Article : Google Scholar : PubMed/NCBI
12	Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:2145–2154. 1991.PubMed/NCBI
13	Hidalgo M and Eckhardt SG: Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst. 93:178–193. 2001. View Article : Google Scholar : PubMed/NCBI
14	Roach DM, Fitridge RA, Laws PE, Millard SH, Varelias A and Cowled PA: Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline. Eur J Vasc Endovasc Surg. 23:260–269. 2002. View Article : Google Scholar : PubMed/NCBI
15	Bachmeier BE, Iancu CM, Jochum M and Nerlich AG: Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach. Expert Rev Anticancer Ther. 5:149–163. 2005. View Article : Google Scholar : PubMed/NCBI
16	Lee SO, Jeong YJ, Im HG, Kim CH, Chang YC and Lee IS: Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells. Biochem Biophys Res Commun. 354:165–171. 2007. View Article : Google Scholar : PubMed/NCBI
17	Dhillon AS, Hagan S, Rath O and Kolch W: MAP kinase signalling pathways in cancer. Oncogene. 26:3279–3290. 2007. View Article : Google Scholar : PubMed/NCBI
18	Bradham C and McClay DR: p38 MAPK in development and cancer. Cell Cycle. 5:824–828. 2006. View Article : Google Scholar : PubMed/NCBI
19	Lee SJ, Kim WJ and Moon SK: Role of the p38 MAPK signaling pathway in mediating interleukin-28A-induced migration of UMUC-3 cells. Int J Mol Med. 30:945–952. 2012.PubMed/NCBI
20	Zhang B, Wang X, Cai F, Chen W, Loesch U, Bitzer J and Zhong XY: Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPK. Tumour Biol. July 7–2012.(Epub ahead of print).
21	Foster FM, Traer CJ, Abraham SM and Fry MJ: The phosphoinositide (PI) 3-kinase family. J Cell Sci. 116:3037–3040. 2003. View Article : Google Scholar : PubMed/NCBI
22	Cotrim CZ, Fabris V, Doria ML, et al: Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells. Oncogene. July 2–2012.(Epub ahead of print).
23	Dineva IK, Zaharieva MM, Konstantinov SM, Eibl H and Berger MR: Erufosine suppresses breast cancer in vitro and in vivo for its activity on PI3K, c-Raf and Akt proteins. J Cancer Res Clin Oncol. June 30–2012.(Epub ahead of print).
24	Park SY, Kim YH, Kim YH and Lee SJ: Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells. J Cell Biochem. June 27–2012.(Epub ahead of print).
25	Nam KS and Shon YH: Suppression of metastasis of human breast cancer cells by chitosan oligosaccharides. J Microbiol Biotechnol. 19:629–633. 2009.PubMed/NCBI
26	Lu N, Ling Y, Gao Y, et al: Endostar suppresses invasion through downregulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells. Exp Biol Med (Maywood). 233:1013–1020. 2008. View Article : Google Scholar : PubMed/NCBI
27	Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 370:61–65. 1994. View Article : Google Scholar : PubMed/NCBI
28	Khokha R: Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst. 86:299–304. 1994. View Article : Google Scholar : PubMed/NCBI
29	Rosenblum G, Meroueh SO, Kleifeld O, et al: Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2). J Biol Chem. 278:27009–27015. 2003. View Article : Google Scholar : PubMed/NCBI
30	Kim ES, Sohn YW and Moon A: TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells. Cancer Lett. 252:147–156. 2007. View Article : Google Scholar
31	Cohen M, Meisser A, Haenggeli L and Bischof P: Involvement of MAPK pathway in TNF-alpha-induced MMP-9 expression in human trophoblastic cells. Mol Hum Reprod. 12:225–232. 2006. View Article : Google Scholar : PubMed/NCBI
32	Kajanne R, Miettinen P, Mehlem A, et al: EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J Cell Physiol. 212:489–497. 2007. View Article : Google Scholar : PubMed/NCBI
33	Westermarck J, Holmström T, Ahonen M, et al: Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38. Matrix Biol. 17:547–557. 1998. View Article : Google Scholar : PubMed/NCBI
34	Cho HJ, Kang JH, Kwak JY, et al: Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis. 28:1104–1110. 2007. View Article : Google Scholar : PubMed/NCBI
35	Hong IK, Kim YM, Jeoung DI, Kim KC and Lee H: Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells. Exp Mol Med. 37:230–239. 2005. View Article : Google Scholar : PubMed/NCBI
36	Wang L, Ling Y, Chen Y, et al: Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett. 297:42–48. 2010. View Article : Google Scholar : PubMed/NCBI
37	Zhang C, Li Y, Qian ZJ, Lee SH, Li YX and Kim SK: Dieckol from Ecklonia cava regulates invasion of human fibrosarcoma cells and modulates MMP-2 and MMP-9 expression via NF-κB pathway. Evid Based Complement Alternat Med. 2011:1404622011.PubMed/NCBI
38	Chen P, Lu N, Ling Y, et al: Inhibitory effects of wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9. Toxicology. 282:122–128. 2011. View Article : Google Scholar : PubMed/NCBI
39	Tang FY, Su YC, Chen NC, Hsieh HS and Chen KS: Resveratrol inhibits migration and invasion of human breast-cancer cells. Mol Nutr Food Res. 52:683–691. 2008. View Article : Google Scholar : PubMed/NCBI
40	Johnson MK and Loo G: Effects of epigallocatechin gallate and quercetin on oxidative damage to cellular DNA. Mutat Res. 459:211–218. 2000. View Article : Google Scholar : PubMed/NCBI
41	Liu PL, Tsai JR, Charles AL, et al: Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases. Mol Nutr Food Res. 54(Suppl 2): S196–S204. 2010. View Article : Google Scholar
42	Lee SJ and Kim MM: Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells. Life Sci. 88:465–472. 2011. View Article : Google Scholar : PubMed/NCBI
43	Park JS, Kim KM, Kim MH, et al: Resveratrol inhibits tumor cell adhesion to endothelial cells by blocking ICAM-1 expression. Anticancer Res. 29:355–362. 2009.PubMed/NCBI
44	Lee MF, Pan MH, Chiou YS, Cheng AC and Huang H: Resveratrol modulates MED28 (Magicin/EG-1) expression and inhibits epidermal growth factor (EGF)-induced migration in MDA-MB-231 human breast cancer cells. J Agric Food Chem. 59:11853–11861. 2011. View Article : Google Scholar : PubMed/NCBI
45	Yar AS, Menevse S and Alp E: The effects of resveratrol on cyclooxygenase-1 and -2, nuclear factor kappa beta, matrix metalloproteinase-9, and sirtuin 1 mRNA expression in hearts of streptozotocin-induced diabetic rats. Genet Mol Res. 10:2962–2975. 2011. View Article : Google Scholar : PubMed/NCBI
46	Weng CJ, Wu CF, Huang HW, Wu CH, Ho CT and Yen GC: Evaluation of anti-invasion effect of resveratrol and related methoxy analogues on human hepatocarcinoma cells. J Agric Food Chem. 58:2886–2894. 2010. View Article : Google Scholar : PubMed/NCBI
47	Liao PC, Ng LT, Lin LT, Richardson CD, Wang GH and Lin CC: Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells. J Med Food. 13:1415–1423. 2010. View Article : Google Scholar : PubMed/NCBI
48	Wang Z, Li W, Meng X and Jia B: Resveratrol induces gastric cancer cell apoptosis via reactive oxygen species, but independent of sirtuin1. Clin Exp Pharmacol Physiol. 39:227–232. 2012. View Article : Google Scholar : PubMed/NCBI